4 recruiting. 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Recruiting 4 |
Follow Newly Diagnosed: new trials by email Literature Review of Newly Diagnosed trials Research Report on Newly Diagnosed
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison of VA (Venetoclax, Azacitidine), VACl (VA, Cladribine), VACh (VA, Chidamide), and Alternating VACl/VACh in Newly Diagnosed Acute Myeloid Leukemia VACl, VACh, VACl Alternating With VACh - Acute Myeloid Leukemia, Adult, Newly Diagnosed | Phase 2 | Recruiting | The First Affiliated Hospital of Soochow University | 172 | 2024-07-29 | 2025-11-19 |
| Zanubrutinib in Combination With Obinutuzumab (ZO) for Newly Diagnosed Follicular Lymphoma Zanubrutinib combined with Obinutuzumab - Follicular Lymphoma, Newly Diagnosed | Phase 2 | Recruiting | The First Affiliated Hospital of Xiamen University | 39 | 2024-03-31 | 2024-09-03 |
| Clinical Study of XPO1 Inhibitor Selinexor Combined With COPL in Newly Diagnosed Advanced NK/T-cell Lymphoma XPO1 inhibitor - nk/T-cell Lymphoma, Newly Diagnosed | Phase 2 | Recruiting | Chinese PLA General Hospital | 10 | 2023-05-01 | 2023-04-27 |
| Venetoclax and Azacitidine Combined With Chidamide (VAC) for the Treatment of Newly Diagnosed Acute Monocytic Leukemia Chidamide, Azacitidine, Venetoclax - Acute Monocytic Leukemia, Newly Diagnosed | Phase 2 | Recruiting | The First Affiliated Hospital of Soochow University | 92 | 2022-03-01 | 2025-11-21 |
Leukemia, Monocytic, Acute (1) · Leukemia, Myeloid, Acute (1) · Lymphoma, Extranodal NK-T-Cell (1) · Lymphoma, Follicular (1)
Neoplasms (4) · Neoplasms by Histologic Type (4) · Hemic and Lymphatic Diseases (3) · Hematologic Diseases (2) · Leukemia (2) · Leukemia, Myeloid (2) · Lymphoma (2) · Lymphoma, Non-Hodgkin (2) · Immune System Diseases (1) · Immunoproliferative Disorders (1) · Leukemia, Myeloid, Acute (1) · Lymphatic Diseases (1) · Lymphoma, T-Cell (1) · Lymphoproliferative Disorders (1)
Azacitidine (1) · N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide (1) · obinutuzumab (1) · venetoclax (1)
The First Affiliated Hospital of Soochow University (2) · Chinese PLA General Hospital (1) · The First Affiliated Hospital of Xiamen University (1)
China (4)
Bing Xu (1) · Sai Huang, Graduate (1) · Sheng-Li Xue, M.D. (1) · Yu Zhao, Graduate (1)